Multi-Agent Treatment Offers Hope in Advanced or Recurrent E

Durvalumab plus olaparib, or alone, paired with chemo boosts PFS in DUO-E trial

Related Keywords

Houston , Texas , United States , Massachusetts , Madrid , Spain , Mike Bassett , Shannon Westin , Md Anderson Cancer Center , European Society For Medical Oncology , Cancer Center , European Society , Medical Oncology ,